EOLS - Evolus, Inc.

Insider activity in EOLS over the last quarter tilts toward selling: insiders offloaded a net 105,108 shares worth roughly $950K.

Classified under Pharmaceuticals (Health Care sector), EOLS's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Moatazedi David	499.6K	$4.52M	-
Other	Avelar Rui	427.4K	$2.03M	-
Dir	Malik Vikram	321.1K	-	-
CFO	Mitchell Tatjana	226.1K	-	-
Dir	Stewart Brady	134.2K	-	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 2, 2026	Moatazedi David67	See Remarks	Sell	105,108	$9.04	$950,018.66	-17.4%	-	-
Mar 20, 2026	Avelar Rui68	See Remarks	Sell	3,119	$4.75	$14,815.25	-0.7%	+42.9%	-
Mar 20, 2026	Moatazedi David67	See Remarks	Sell	13,669	$4.75	$64,929.12	-2.2%	+42.9%	-
Mar 17, 2026	Moatazedi David67	See Remarks	Sale+OE	116,720	$4.89	$570,562.38	-15.9%	+37.5%	-
Mar 17, 2026	Avelar Rui68	See Remarks	Sale+OE	29,996	$4.89	$146,629.45	-6.5%	+37.5%	-
Dec 22, 2025	Moatazedi David67	See Remarks	Sell	10,539	$7.15	$75,361.23	-2.9%	-34.9%	-
Dec 22, 2025	Avelar Rui68	See Remarks	Sell	2,261	$7.15	$16,167.73	-0.6%	-34.9%	-
Aug 22, 2025	Yamagishi-Dressler Tomoko74	Chief Marketing Officer	Sell	5,722	$7.51	$42,972.22	-6.0%	-13.8%	+9.2%
Aug 15, 2025	Stewart Brady	Director	Buy	30,000	$6.82	$204,486.00	+51.2%	+9.5%	+21.2%
Jun 16, 2025	Moatazedi David67	See Remarks	Sell	127,905	$10.03	$1,283,195.27	-26.0%	-33.4%	-33.4%